Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-03-13 4:00 pm Purchase | 2023-03-03 | 13G | AMBRX BIOPHARMA INC SPONSORED AMAM | Cormorant Asset Management LP | 52,500,000 17.730% | 36,145,298 (+221.01%) | Filing History |
| 2023-02-14 3:15 pm Sale | 2022-12-31 | 13G | ELEVATION ONCOLOGY INC ELEV | Cormorant Asset Management LP | 1,952,032 8.380% | -31,136 (-1.57%) | Filing History |
| 2023-02-14 3:14 pm Sale | 2022-12-31 | 13G | CONSTELLATION PHARMACEUTICALS CNST | Cormorant Asset Management LP | 5,150,000 9.210% | -290,451 (-5.34%) | Filing History |
| 2023-02-14 3:13 pm Sale | 2022-12-31 | 13G | GREENLIGHT BIOSCIENCES HLDGS P GRNA | Cormorant Asset Management LP | 9,188,659 6.060% | -290,399 (-3.06%) | Filing History |
| 2023-02-14 3:13 pm Purchase | 2022-12-31 | 13G | IMMUNEERING CORP IMRX | Cormorant Asset Management LP | 2,286,181 8.660% | 33,553 (+1.49%) | Filing History |
| 2023-02-14 3:12 pm Sale | 2022-12-31 | 13G | AMBRX BIOPHARMA INC SPONSORED AMAM | Cormorant Asset Management LP | 16,354,702 6.050% | -911,442 (-5.28%) | Filing History |
| 2023-02-14 3:11 pm Sale | 2022-12-31 | 13G | MONTE ROSA THERAPEUTICS INC CO GLUE | Cormorant Asset Management LP | 2,893,717 5.980% | -108,483 (-3.61%) | Filing History |
| 2023-02-14 3:10 pm Purchase | 2022-12-31 | 13G | BIOATLA INC BCAB | Cormorant Asset Management LP | 3,680,365 7.980% | 1,642,150 (+80.57%) | Filing History |
| 2023-02-14 3:10 pm Purchase | 2022-12-31 | 13G | AEROVATE THERAPEUTICS INC AVTE | Cormorant Asset Management LP | 55,918 7.950% | 3,613 (+6.91%) | Filing History |
| 2023-02-14 3:09 pm Sale | 2022-12-31 | 13G | CABALETTA BIO INC CABA | Cormorant Asset Management LP | 1,971,739 6.770% | -28,261 (-1.41%) | Filing History |
| 2023-02-14 3:08 pm Sale | 2022-12-31 | 13G | ARCELLX INC ACLX | Cormorant Asset Management LP | 2,075,000 4.730% | -125,000 (-5.68%) | Filing History |
| 2023-02-14 3:08 pm Sale | 2022-12-31 | 13G | OLEMA PHARMACEUTICALS INC OLMA | Cormorant Asset Management LP | 2,082,000 5.150% | -87,871 (-4.05%) | Filing History |
| 2023-02-14 3:07 pm Sale | 2022-12-31 | 13G | ALTIMMUNE INC ALT | Cormorant Asset Management LP | 2,600,000 5.290% | -400,000 (-13.33%) | Filing History |
| 2023-02-14 3:05 pm Sale | 2022-12-31 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Cormorant Asset Management LP | 1,100,000 2.730% | -336,322 (-23.42%) | Filing History |
| 2023-02-14 3:05 pm Purchase | 2022-12-31 | 13G | LONGBOARD PHARMACEUTICALS INC LBPH | Cormorant Asset Management LP | 1,801,947 9.990% | 420,015 (+30.39%) | Filing History |
| 2023-02-14 3:04 pm Purchase | 2022-12-31 | 13G | TARSUS PHARMACEUTICALS INC TARS | Cormorant Asset Management LP | 1,736,422 6.510% | 333,091 (+23.74%) | Filing History |
| 2023-02-14 3:03 pm Purchase | 2022-12-31 | 13G | ASTRIA THERAPEUTICS INC ATXS | Cormorant Asset Management LP | 1,650,000 6.300% | 450,000 (+37.50%) | Filing History |
| 2023-02-14 3:03 pm Sale | 2022-12-31 | 13G | VECTIVBIO HLDG AG VECT | Cormorant Asset Management LP | 2,536,617 4.040% | -303,772 (-10.69%) | Filing History |
| 2023-02-14 3:02 pm Sale | 2022-12-31 | 13G | TANGO THERAPEUTICS INC TNGX | Cormorant Asset Management LP | 4,116,949 4.670% | -782,235 (-15.97%) | Filing History |
| 2023-02-14 3:01 pm Sale | 2022-12-31 | 13G | PROMETHEUS BIOSCIENCES INC RXDX | Cormorant Asset Management LP | 2,090,000 4.500% | -134,847 (-6.06%) | Filing |